Optimal use of clotting factors and platelets
The symposium “Optimal use of clotting factors and immunoglobulins” was held on 26 and 27 April 2013 in Wildbad Kreuth (Germany) in the tradition of two previous symposia held in the same place. The first symposium in 1999, “Blood safety in the European Community: An initiative for optimal use” provided the basis for discussion. The second symposium, held in 2009, on “Optimal clinical use of blood components” took the topic further for a variety of blood components. The 2013 symposium focused on clotting factors and immunoglobulins. This latter topic had not been included in the previous symposia. This book presents the proceedings of the 2013 Kreuth symposium. It is based on the scientific presentations and debates held during the general sessions and workshops, their consensual conclusions and the final recommendations. The outcome is an updated appraisal of the state of the art in optimal clinical use of clotting factors and immunoglobulins. It can be regarded as an international reference, and will be of particular interest to relevant stakeholders, including scientific and professional societies.